TB Archives – Page 15 of 48 – Treatment Action Group

Treatment Action Group Regrets NYC Health Commissioner Oxiris Barbot’s Resignation

August 6, 2020
Dorrit Walsh

Treatment Action Group, the New York City-based research, policy, and advocacy organization, deplores the August 4, 2020 departure of New York’s Department of Health Commissioner, Dr. Oxiris Barbot, MD.

Letter to Sanofi CEO Calling for Patent Withdrawals on Critical TB Drugs

August 3, 2020
Dorrit Walsh

TAG and our French partners OTMeds (Observatoire de la transparence dans les politiques du médicaments) sent a letter to Sanofi CEO Paul Hudson calling on the company to reverse its efforts to patent two obvious combinations of two critical drugs to prevent tuberculosis: rifapentine and isoniazid.

Cover image of publication, An Activist's Guide to TB Diagnostic Tools

An Activist’s Guide to Tuberculosis Diagnostic Tools

July 28, 2020
Dorrit Walsh

Our publication, An Activist’s Guide to Tuberculosis Diagnostic Tools, details the latest WHO recommendations, the array of available TB diagnostic tools, and how these tools should be optimally used in country programs, including to support TB screening and diagnosis among special populations such as children, people with extrapulmonary TB, and people living with HIV/AIDS (PLWHA).

In Memoriam – The Honorable John Lewis

July 21, 2020
Dorrit Walsh

Treatment Action Group (TAG) honors the titanic historic legacy and mourns the recent death of the Honorable John Lewis, U.S. Representative from the 5th Congressional district in Georgia and legendary civil rights leader.

Global Health and Human Rights Organizations Say U.S. Withdrawal from WHO Is Reckless Act That Could Delay Americans’ Access to COVID-19 Solutions and Prolong Global Pandemic

July 7, 2020
Dorrit Walsh

AVAC, Health GAP and the Treatment Action Group (TAG) strongly condemn the Trump Administration’s withdrawal from the World Health Organization (WHO).

Treatment Action Group Statement on Bedaquiline Unaffordability

July 6, 2020
Dorrit Walsh

Treatment Action Group welcomes the Global Drug Facility / Stop TB Partnership's negotiation of what amounts to a 32% savings on bedaquiline, the backbone of improved, all-oral regimens for treating drug-resistant TB.

2020 Pipeline Report

July 2, 2020
Dorrit Walsh

Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

Treatment Action Group Commemorates Juneteenth through Solidarity Actions, Reflection, and Transparency

June 18, 2020
Dorrit Walsh

Tomorrow, Treatment Action Group (TAG) will be observing and honoring Juneteenth—a commemoration of the end of slavery in the United States—through a day of solidarity, actions, and reflection.

Podcast with Dr. Madhukar Pai: TB Diagnostics Advocacy in the Context of COVID-19

June 12, 2020
Dorrit Walsh

On this podcast, Dr. Madhukar Pai describes the ways that the COVID-19 pandemic has delayed and limited access to TB diagnostic testing, and how all stakeholders must step-up efforts to mitigate these impacts and ensure that TB diagnostic testing is not abandoned in the response to COVID-19.

2019 Annual Report

June 9, 2020
Dorrit Walsh

2019 was a year of significant progress against HIV, tuberculosis (TB), and hepatitis C virus (HCV). We shaped policy and legislation to end these conditions, secured increased funding to do so at various levels of government, and stood up for the rights of affected communities.